Thrombolytic therapy for submassive/intermediate risk Pulmonary Embolism Evidence and suggestions after PEITHO trial

被引：1

作者：

Marin V., Arnaldo ^{[1
]}

Tomas Gazmuri B., Jose ^{[2
]}

Andresen V., Max ^{[4
]}

Andresen, Max ^{[3
]}

机构：

[1] Univ Chile, Fac Med, Hosp Clin Univ Chile, Med Interna, Santiago 7, Chile

[2] Univ Los Andes, Fac Med, Med Interna, Santiago, Chile

[3] Pontificia Univ Catolica Chile, Fac Med, Dept Med Intens, Santiago, Chile

[4] Pontificia Univ Catolica Chile, Fac Med, Interno Med, Santiago, Chile

来源：

REVISTA MEDICA DE CHILE | 2015年 / 143卷 / 07期

关键词：

Pulmonary embolism; Shock; Thrombectomy; Thrombolytic therapy; RIGHT-VENTRICULAR DYSFUNCTION; TISSUE PLASMINOGEN-ACTIVATOR; MULTICENTER DOUBLE-BLIND; INTRACRANIAL HEMORRHAGE; PROGNOSTIC VALUE; MANAGEMENT; ALTEPLASE; OUTCOMES; HEPARIN; TENECTEPLASE;

D O I：

10.4067/S0034-98872015000700011

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Therapy for submassive pulmonary embolism (intermediate risk), remains controversial. New evidence has appeared that may help us in the process of decision making. We review the relevant literature, outline prognostic factors, and discuss current recommendations and controversies regarding the available alternatives such as systemic and catheter-directed thrombolytic use.

引用

页码：895 / 904

页数：10

共 50 条

[1] Systemic Thrombolytic Therapy for Massive and Submassive Pulmonary Embolism
Igneri, Lauren A.
Hammer, John M.
JOURNAL OF PHARMACY PRACTICE, 2020, 33 (01) : 74 - 89
[2] Thrombolytic therapy for submassive pulmonary embolism
Lankeit, Mareike
Konstantinides, Stavros
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2012, 25 (03) : 379 - 389
[3] Impact of the efficacy of thrombolytic therapy on the mortality of patients with acute submassive pulmonary embolism: a meta-analysis
Nakamura, S.
Takano, H.
Kubota, Y.
Asai, K.
Shimizu, W.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (07) : 1086 - 1095
[4] Massive and Submassive Pulmonary Embolism: Diagnostic Challenges and Thrombolytic Therapy
Swaminathan, Anand
ACADEMIC EMERGENCY MEDICINE, 2014, 21 (02) : 208 - 210
[5] The Role of Thrombolytic Therapy for Patients with a Submassive Pulmonary Embolism
Murphy, Elizabeth
Lababidi, Ahmed
Reddy, Renuka
Mendha, Taaha
Lebowitz, David
CUREUS, 2018, 10 (06):
[6] Value of thrombolytic therapy for submassive pulmonary embolism patients
Ahmed, Magda A.
Abdelsalam, Sherif, I
Elmorsy, Rehab A.
EGYPTIAN JOURNAL OF CHEST DISEASES AND TUBERCULOSIS, 2018, 67 (04): : 413 - 418
[7] Thrombolytic and anticoagulant therapy for acute submassive pulmonary embolism
Fei, Jianwen
Tang, Yan
Wu, Jinxiang
Kang, Lijun
Zhao, Jiping
Dai, Hong
Bi, Wenxiang
Wang, Junfei
Liu, Fen
Liu, Wen
Yang, Meng
Dong, Liang
EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2014, 7 (01) : 103 - 108
[8] Thrombolytic therapy for pulmonary embolism
Meyer, G.
JOURNAL DES MALADIES VASCULAIRES, 2011, 36 : S33 - S36
[9] Four key questions surrounding thrombolytic therapy for submassive pulmonary embolism
Sista, Akhilesh K.
Horowitz, James M.
Goldhaber, Samuel Z.
VASCULAR MEDICINE, 2016, 21 (01) : 47 - 52
[10] Thrombolytic therapy in acute pulmonary embolism
Tapson, Victor F.
CURRENT OPINION IN CARDIOLOGY, 2012, 27 (06) : 585 - 591

← 1 2 3 4 5 →